Recall Register

Drug recall: 20% Acetyl-L-Cysteine Ophthalmic Solutions, dispensed in 3ml dropper bottle.

Class II FDA enforcement event 83722. Recall start date: . Status in the FDA record: Terminated. Termination date: .

Reason for recall, in the words of FDA

Lack of Processing Controls:

Class II, in the words of FDA

a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote

Compounded Solutions in Pharmacy started this drug recall on 3 Sep 2019. The firm address in the FDA record is in Monroe, CT. FDA put the recall in Class II. FDA event 83722 has 3 product records. The first FDA enforcement report date is 18 Sep 2019. The record gives the status Terminated, with the termination date 4 Mar 2020.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

Product was dispensed to patients

Recalling firm

Compounded Solutions in Pharmacy, Monroe, CT.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

3 product records in the event.

FDA event 83722: product records
Recall numberProductQuantityClassStatusReport date
D-1853-201920% Acetyl-L-Cysteine Ophthalmic Solutions, dispensed in 3ml dropper bottle.3x3 ml dropper bottlesClass IITerminated18 Sep 2019
D-1854-201910% Acetyl-L-Cysteine Ophthalmic Solutions, dispensed in a) 5ml, b) 10ml c) 15 ml, dropper bottlesa) 6x5ml b) 4x10 c) 1x15 ml bottles,Class IITerminated18 Sep 2019
D-1855-20195% Acetyl-L-Cysteine Ophthalmic Solutions, dispensed in a) 5ml , b) 10ml dropper bottlesa) 4x5 ml, b) 1x10 ml bottlesClass IITerminated18 Sep 2019

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class II: The middle of the three FDA recall classes.

The event in context

Drug events that started in 2019
362
Share of these events in Class II
68%
Product records in this event
3
Events of the firm on the register
1

Official channels

Cite this page

Recall Register. FDA enforcement event 83722. https://recallregister.com/fda/ii/83722/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA drug enforcement reports
Licence
CC0 1.0
Export date
28 Sep 2026
Newest FDA report date on the register
23 Sep 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: Product was dispensed to patients
What quantity of product is in FDA event 83722?
The event has 3 product records. The first record gives this quantity: 3x3 ml dropper bottles
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many drug recalls of 2019 have the same class?
68% of the 362 drug events that started in 2019 are in Class II.